Anti-SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?

Gastroenterology. 2021 Dec;161(6):2057-2059. doi: 10.1053/j.gastro.2021.09.019. Epub 2021 Sep 14.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibody Formation
  • Biological Products* / adverse effects
  • COVID-19*
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • SARS-CoV-2

Substances

  • Biological Products